HexyDog Launches Vision for Blockchain-Powered Payments to Support Animal Welfare
LONDON, April 09, 2025 (GLOBE NEWSWIRE) -- HexyDog, a next-generation blockchain project focused on real-world adoption, has unveiled its upcoming decentralized payment ecosystem tailored to the pet care industry. Designed to support seamless, secure, and low-cost payments across pet shops, grooming salons, and veterinary clinics, the platform combines Web3 technology with a social impact mission.
Currently in its presale phase, HexyDog is building a multi-chain ecosystem powered by the HEXY token, which aims to revolutionize how pet businesses process transactions. The project enables businesses to accept crypto payments, cut high processing fees, and engage with a growing base of tech-savvy pet owners who prefer decentralized solutions.
A Blockchain Solution for the Pet Economy
HexyDog is more than just a meme coin—it's a functional crypto utility tailored for the pet industry. It empowers merchants with:
Instant, Borderless Payments: Say goodbye to third-party delays with direct, real-time settlements.
Lower Transaction Fees: Reduce overhead compared to traditional credit cards and payment gateways.
Immutable Ledger: Built-in blockchain security ensures transactions are tamper-proof and transparent.
Growing Crypto Adoption: Pet brands can now connect with Web3-native consumers eager to transact in digital assets.
Real-World Partnerships and Purpose
HexyDog's blockchain ecosystem isn't just theoretical—it's designed for practical deployment. By partnering with pet businesses, HexyDog is building pathways for HEXY token utility beyond speculation. The project's roadmap includes smart contract integration for efficient transactions and listings on key centralized exchanges (CEX) to increase liquidity and adoption.
The team is also developing an Ambassador Program to drive community involvement and outreach. Volunteers will be able to participate in advocacy, grassroots campaigns, and real-world animal welfare activities aligned with HexyDog's mission.
Supporting Animal Welfare
Aside from its blockchain payment project, HexyDog is also extremely committed to animal welfare. 5% of the presale proceeds will be donated directly to animal welfare groups, including shelters, rescue groups, and other groups that aim to improve the lives of animals.
Impact on Animal Welfare
This special commitment ensures that HexyDog is about more than just financial expansion. By investing part of presale crypto capital into promoting animal welfare, HexyDog unites investors and pet lovers around a good cause they can contribute to. Through this philanthropic business model, the project will be able to make a social impact while pushing adoption within the pet care space through cryptocurrencies.
HexyDog Appeal Among Pet Lovers and Investors
For investors, HexyDog offers the unique opportunity to be investor of a promising crypto presale project that combines blockchain technology with a growing market within the pet care industry. As it is aimed at efficient payment, social good, and developing market, HexyDog can be an excellent investment for whoever is ready to explore opportunities crypto space provides.
This crypto presale provides early investors with the ability to purchase HEXY tokens at a discounted price, positioning them for appreciation when the whole project is live. With crypto adoption still on the rise, HexyDog will be perfectly positioned to be one of the leaders in the blockchain industry, and as an investment, it is a sound option.
The Future of Pet Care Payments
HexyDog is a great candidate to revolutionize blockchain industry by integrating it into pet market . HexyDog, through its blockchain solution, will offer faster, secure, and low-cost payments for businesses and consumers alike. By devoting 5% of presale funds to animal welfare, HexyDog also ensures that the project gives back to society in a positive way.
As the use of cryptocurrencies keeps growing, HexyDog will be a leader in the pet care industry. It is a wonderful opportunity for pet businesses and investors to be part of an innovative project that will revolutionize the future of the industry while supporting a noble cause.
About HexyDog
HexyDog is a blockchain-based cryptocurrency project that merges decentralized finance with real-world pet care applications. The platform enables crypto-based payments in the pet industry, supported by a strong community, partnerships, and a social mission to fund animal welfare. Learn more or join the presale at https://hexydog.com.
Media Contact Details:
Company Name: Hexydog
Company website: https://hexydog.com
Concern Person: Onur Akin
Disclaimer: This press release is provided by Hexydog. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice.Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. However, due to the inherently speculative nature of the blockchain sector—including cryptocurrency, NFTs, and mining—complete accuracy cannot always be guaranteed.Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility.
Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
KFSHRC Pioneering Clinical Trials and Gene Therapy Across the Region
KFSHRC accounts for 52.4% of all active clinical trials in Saudi Arabia. RIYADH, Saudi Arabia, June 04, 2025 (GLOBE NEWSWIRE) -- As part of Saudi Arabia's broader biotechnology transformation under Vision 2030, King Faisal Specialist Hospital & Research Centre (KFSHRC) solidified its role as the Kingdom's leading Clinical Trials hub in 2024 — conducting 52.4% of all active Clinical Trials nationwide, according to the Saudi National Institute of Health. This milestone reflects the sustained success of KFSHRC's Clinical Trials Transformation Initiative, launched in 2021 to build an integrated, patient-centered research ecosystem. By the end of 2024, the hospital had recorded 701 active research proposals, representing an 8% increase over the previous year. In Riyadh alone, research approvals rose by 20%, demonstrating growing alignment between scientific discovery and clinical care delivery. KFSHRC's research growth was matched by key innovation milestones. In 2024, it became the first in Saudi Arabia to locally produce CAR-T cells — a major step toward national self-sufficiency in advanced therapies. It also delivered a breakthrough in hemophilia care, using one-time gene therapy to restore clotting function in eight patients, eliminating preventive treatment and significantly improving quality of life. These advancements align closely with Saudi Arabia's Vision 2030 and National Biotechnology Strategy, which designate biotechnology as a national priority sector — aiming to localize therapeutic development, accelerate innovation, and establish global leadership by 2040. Complementing its scientific leadership, KFSHRC has also invested in public engagement, launching awareness campaigns in high-traffic public venues to promote Clinical Trials literacy and reduce misconceptions around participation. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world's top 250 Academic Medical Centres for the third consecutive year, and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit or contact our media team at mediacoverage@ A photo accompanying this announcement is available at
Yahoo
an hour ago
- Yahoo
Apple stock hit with downgrade by Needham analysts, citing stiff AI competition
Apple (AAPL) stock was downgraded to Hold from Buy by Needham analysts who said the stock is overvalued amid growing AI competition. Analyst Laura Martin explained in a note to clients Wednesday that Apple is currently trading at a more expensive multiple than it has historically, just as the rise of generative AI threatens to disrupt the iPhone maker's businesses. Apple is currently the worst-performing stock of its "Magnificent Seven" Big Tech peers, down roughly 18% for the year. The company has faced lagging sales in China and a sluggish smartphone market. The stock was hit with two downgrades in January from Jefferies and Loop Capital. Shares, which stood just above $200 on Wednesday, are priced at roughly 26 times the company's projected 2026 earnings, a multiple 50% above its 10-year average and 25% above the current average forward-year 2026 price-to-earnings ratio for the S&P 500 (^GSPC), Martin noted. "We believe that, for this stock to work, it must have the catalyst of an iPhone replacement cycle, which we do not foresee in the next 12 months," Martin wrote. "Until then, we believe that $170-$180/share is a better entry level." She also said Apple could accelerate growth by deciding to "aggressively pursue an advertising revenue stream." Needham's downgrade comes as the smartphone market at large is experiencing a slump: Counterpoint Research on Wednesday lowered its 2025 annual growth forecast for global smartphone shipments to 1.9% from 4.2%, citing uncertainties related to US tariffs. Meanwhile, Apple is facing growing competition in AI. Martin wrote that "every Big Tech company is building platforms designed to displace AAPL's integrated hardware and software products in a GenAI [generative artificial intelligence] world." That includes Meta's AI smartglasses, as well as OpenAI and Jony Ive's development of a new mystery AI hardware device that could offer an AI alternative to smartphones, the analyst said. Apple also doesn't reap the benefits of AI Cloud revenue like its competitors. "While peers like Microsoft (MSFT), Google (GOOG), and Meta (META) are launching foundational models and GenAI-native platforms, AAPL still lacks a competitive LLM [large language model] or a developer ecosystem around GenAI capabilities," Martin wrote. In April, Apple stock's 200-day moving average rose above its 50-day moving average, a phenomenon called a "death cross." "This pattern is typically viewed as a bearish signal, indicating continued downward momentum," Martin wrote. The company faces other risk factors, such as the potential threat of losing $20 billion in annual revenue from Google as the Alphabet-owned (GOOGL, GOOG) tech giant awaits final orders from US Judge Amit Mehta in its landmark antitrust case. Apple is also staring down its own antitrust case. Apple is also getting pressured on the supply side: Trump is threatening a 25% tariff on its iPhones unless the company shifts production to the US, a process that could take more than five years. The company's culture may not help as it grapples with myriad challenges. Martin said in her note, "AAPL believes that it makes its own weather. This philosophy reflects a deep-seated cultural belief that AAPL operates on its own terms, largely independent of external trends, competitive pressures, or even macroeconomic conditions." The analyst said she worries that Apple's culture "[b]reeds complacency, which lowers urgency just as GenAI disruption threatens to re-tool the entire US economy," and "[m]akes AAPL slow to acknowledge negative shifts in the regulatory environment and rising geopolitical risks." Laura Bratton is a reporter for Yahoo Finance. Follow her on Bluesky @ Email her at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Apple stock hit with downgrade by Needham analysts, citing stiff AI competition
Apple (AAPL) stock was downgraded to Hold from Buy by Needham analysts who said the stock is overvalued amid growing AI competition. Analyst Laura Martin explained in a note to clients Wednesday that Apple is currently trading at a more expensive multiple than it has historically, just as the rise of generative AI threatens to disrupt the iPhone maker's businesses. Apple is currently the worst-performing stock of its "Magnificent Seven" Big Tech peers, down roughly 18% for the year. The company has faced lagging sales in China and a sluggish smartphone market. The stock was hit with two downgrades in January from Jefferies and Loop Capital. Shares, which stood just above $200 on Wednesday, are priced at roughly 26 times the company's projected 2026 earnings, a multiple 50% above its 10-year average and 25% above the current average forward-year 2026 price-to-earnings ratio for the S&P 500 (^GSPC), Martin noted. "We believe that, for this stock to work, it must have the catalyst of an iPhone replacement cycle, which we do not foresee in the next 12 months," Martin wrote. "Until then, we believe that $170-$180/share is a better entry level." She also said Apple could accelerate growth by deciding to "aggressively pursue an advertising revenue stream." Needham's downgrade comes as the smartphone market at large is experiencing a slump: Counterpoint Research on Wednesday lowered its 2025 annual growth forecast for global smartphone shipments to 1.9% from 4.2%, citing uncertainties related to US tariffs. Meanwhile, Apple is facing growing competition in AI. Martin wrote that "every Big Tech company is building platforms designed to displace AAPL's integrated hardware and software products in a GenAI [generative artificial intelligence] world." That includes Meta's AI smartglasses, as well as OpenAI and Jony Ive's development of a new mystery AI hardware device that could offer an AI alternative to smartphones, the analyst said. Apple also doesn't reap the benefits of AI Cloud revenue like its competitors. "While peers like Microsoft (MSFT), Google (GOOG), and Meta (META) are launching foundational models and GenAI-native platforms, AAPL still lacks a competitive LLM [large language model] or a developer ecosystem around GenAI capabilities," Martin wrote. In April, Apple stock's 200-day moving average rose above its 50-day moving average, a phenomenon called a "death cross." "This pattern is typically viewed as a bearish signal, indicating continued downward momentum," Martin wrote. The company faces other risk factors, such as the potential threat of losing $20 billion in annual revenue from Google as the Alphabet-owned (GOOGL, GOOG) tech giant awaits final orders from US Judge Amit Mehta in its landmark antitrust case. Apple is also staring down its own antitrust case. Apple is also getting pressured on the supply side: Trump is threatening a 25% tariff on its iPhones unless the company shifts production to the US, a process that could take more than five years. The company's culture may not help as it grapples with myriad challenges. Martin said in her note, "AAPL believes that it makes its own weather. This philosophy reflects a deep-seated cultural belief that AAPL operates on its own terms, largely independent of external trends, competitive pressures, or even macroeconomic conditions." The analyst said she worries that Apple's culture "[b]reeds complacency, which lowers urgency just as GenAI disruption threatens to re-tool the entire US economy," and "[m]akes AAPL slow to acknowledge negative shifts in the regulatory environment and rising geopolitical risks." Laura Bratton is a reporter for Yahoo Finance. Follow her on Bluesky @ Email her at
